Role of circ_0003633 in osimertinib resistance in lung adenocarcinoma cells
CSTR:
Author:
Affiliation:

Department of Oncology,the Second Affiliated Hospital of Nanjing Medical University,Nanjing 210011 ,China

Clc Number:

R734.2

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To explore the role of circ_0003633 in osimertinib resistance of lung adenocarcinoma cells. Methods:By performing circRNA sequencing on osimertinib - resistant and sensitive cells,circ_0003633 was identified as significantly highly expressed in the resistant cells. The expression of circ_0003633 was knocked down in osimertinib - resistant cells,and its role in osimertinib - resistant lung adenocarcinoma cells was investigated through CCK - 8 assay,Transwell assay and colony formation assay. RNA pulldown assay,transcriptome sequencing and bioinformatics analysis were used to screen downstream target genes and signaling pathways. Results:circ_0003633 was significantly highly expressed in osimertinib - resistant cells. Knockdown of circ_0003633 enhanced the sensitivity of resistant cells to osimertinib. circ_0003633 bound to RNA - binding protein hnRNPA1 and regulated the downstream target gene ALDOC to exert its biological functions. Conclusion:circ_0003633 is highly expressed in osimertinib - resistant cells,binds to hnRNPA1,and regulates the downstream target gene ALDOC,thereby activating the PI3K/AKT signaling pathway to promote the resistance of lung adenocarcinoma cells to osimertinib. It may serve as a potential therapeutic target for reversing drug resistance.

    Reference
    Related
    Cited by
Get Citation

ZHANG Ge, CHEN Xin, GU Jingyao, WANG Zhaoxia. Role of circ_0003633 in osimertinib resistance in lung adenocarcinoma cells[J].,2025,45(9):1229-1241.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 29,2025
  • Revised:
  • Adopted:
  • Online: September 11,2025
  • Published:
Article QR Code